Comparison of Long Term Effects of Treatment of Different CFTR Modulators in People With Cystic Fibrosis
Pediatric Pulmonology · 2026
DOI: 10.1002/ppul.71681 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pediatric Pulmonology, 2026. Verfasst von Paulina Famulska und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Cystic Fibrosis, Polanki Children's Hospital, Gdańsk, Poland. Hauptthemen laut MEDLINE: Cystic Fibrosis, Quinolones, Aminophenols, Benzodioxoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
Background
Cystic fibrosis transmembrane conductance regulator modulators (CFTRm) represent a breakthrough in the treatment of people with cystic fibrosis (PwCF), offering improvements in health outcomes and quality of life (QoL) previously unattainable.
Objective
To descriptively evaluate 12‐month outcomes during treatment with three CFTRm therapies in a real‐world cohort of children and adults with CF.
Methods
This prospective, observational study included 146 PwCF aged 2–56 years treated at two Polish CF centres. Patients received lumacaftor/ivacaftor (LUM/IVA), tezacaftor/ivacaftor (TEZ/IVA) or elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA). Assessments were conducted at baseline and every 3 months over 12 months. Parameters evaluated included spirometry, impulse oscillometry (IOS), lung clearance index (LCI), anthropometric data, serum vitamin D3, sweat chloride (SwCl), lung imaging (Brasfield score), general clinical status – Schwachman‐Kulczycki (S‐K score), and quality of life (QoL). Statistical analyses were performed using the software R (v. 4.4.1).
Results
Most parameters improved over time, with response magnitude varying by treatment. Significant improvements were observed in forced expiratory volume in 1 s (FEV 1 ), forced vital capacity (FVC), maximal expiratory flow at 50% of vital capacity (MEF 50 ), LCI, most IOS parameters, SwCl, anthropometric parameters, Brasfield and S‐K scores. Vitamin D3 concentrations and resistance at 5 Hz (R5) did not change significantly. All therapies led to better QoL.
Conclusions
CFTRm – particularly ELX/TEZ/IVA – demonstrated substantial clinical benefits across age groups. The treatment effect varied over time in the majority of patients. Different CFTRm's impact on respiratory function, nutritional status, and well‐being underscores the importance of personalized approaches in CF care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics and Cystic Fibrosis, Polanki Children's Hospital, Gdańsk, Poland.
- Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poznań, Poland.
- Department of Paediatric Pulmonology, Allergy and Clinical Immunology, Poznan University of Medical Sciences, Poznań, Poland.
- Department of Diabetology, Auxology and Paediatric Obesity, Poznan University of Medical Sciences, Poznań, Poland.
ORCID-Profile: Paulina Famulska, Ewa Sapiejka, Marta Osińska, Katarzyna Tąpolska-Jóźwiak, Anna Wiesner, Maria Jóźwiak, Irena Wojsyk-Banaszak
Zitieren
APA
Famulska, P., Więckowska, B., Narożna, B., Sapiejka, E., Osińska, M., Musiał, A., Szczepankiewicz, A., Tąpolska-Jóźwiak, K., Wiesner, A., Steinert-Dymecki, A., Jóźwiak, M., & Wojsyk-Banaszak, I. (2026). Comparison of Long Term Effects of Treatment of Different CFTR Modulators in People With Cystic Fibrosis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71681
Vancouver
Famulska P, Więckowska B, Narożna B, Sapiejka E, Osińska M, Musiał A, et al. Comparison of Long Term Effects of Treatment of Different CFTR Modulators in People With Cystic Fibrosis. Pediatric Pulmonology. 2026. doi:10.1002/ppul.71681
BibTeX
@article{Famulska2026,
author = {Famulska, Paulina and Więckowska, Barbara and Narożna, Beata and Sapiejka, Ewa and Osińska, Marta and Musiał, Anna and Szczepankiewicz, Aleksandra and Tąpolska-Jóźwiak, Katarzyna and Wiesner, Anna and Steinert-Dymecki, Anna and Jóźwiak, Maria and Wojsyk-Banaszak, Irena},
title = {Comparison of Long Term Effects of Treatment of Different CFTR Modulators in People With Cystic Fibrosis},
journal = {Pediatric Pulmonology},
year = {2026},
doi = {10.1002/ppul.71681}
}
EUVIMED